celecoxib has been researched along with Gastritis in 9 studies
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
Excerpt | Relevance | Reference |
---|---|---|
"To see whether celecoxib prevents gastric cancer occurrence by disrupting the progression of chronic gastritis into gastric carcinoma through its inhibition of the migration of CD133-positive cells, one of the surface markers of bone marrow-derived cells, in Helicobacter pylori-infected gerbils." | 3.76 | Celecoxib inhibits CD133-positive cell migration via reduction of CCR2 in Helicobacter pylori-infected Mongolian gerbils. ( Futagami, S; Gudis, K; Hamamoto, T; Horie, A; Kawagoe, T; Nagoya, H; Sakamoto, C; Shimpuku, M; Shindo, T, 2010) |
" The objective of this study was to evaluate the risk of upper GI adverse events associated with celecoxib and oral and parenteral non-selective NSAIDs in cirrhotic patients." | 1.38 | Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients. ( Chang, CH; Chen, HC; Lai, MS; Lee, YC; Lin, JW; Lin, MS, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (66.67) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ranatunge, RR | 1 |
Augustyniak, M | 1 |
Bandarage, UK | 1 |
Earl, RA | 1 |
Ellis, JL | 1 |
Garvey, DS | 1 |
Janero, DR | 1 |
Letts, LG | 1 |
Martino, AM | 1 |
Murty, MG | 1 |
Richardson, SK | 1 |
Schroeder, JD | 1 |
Shumway, MJ | 1 |
Tam, SW | 1 |
Trocha, AM | 1 |
Young, DV | 1 |
Gupta, A | 1 |
Zheng, L | 1 |
Ramanujam, V | 1 |
Gallagher, J | 1 |
Dutta, N | 1 |
Sarotra, P | 1 |
Gupta, S | 1 |
Aggarwal, R | 1 |
Agnihotri, N | 1 |
Futagami, S | 1 |
Hamamoto, T | 1 |
Shimpuku, M | 1 |
Nagoya, H | 1 |
Kawagoe, T | 1 |
Horie, A | 1 |
Shindo, T | 1 |
Gudis, K | 1 |
Sakamoto, C | 1 |
Lee, YC | 1 |
Chang, CH | 1 |
Lin, JW | 1 |
Chen, HC | 1 |
Lin, MS | 1 |
Lai, MS | 1 |
Saukkonen, K | 1 |
Tomasetto, C | 1 |
Narko, K | 1 |
Rio, MC | 1 |
Ristimäki, A | 1 |
Lugardon, S | 1 |
Lapeyre-Mestre, M | 1 |
Montastruc, JL | 1 |
Moride, Y | 1 |
Ducruet, T | 1 |
Boivin, JF | 1 |
Moore, N | 1 |
Perreault, S | 1 |
Zhao, S | 1 |
Swaak, AJ | 1 |
Theunissen, DJ | 1 |
9 other studies available for celecoxib and Gastritis
Article | Year |
---|---|
Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles.
Topics: Administration, Oral; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cycl | 2004 |
Novel Use of Pharmacogenetic Testing in the Identification of CYP2C9 Polymorphisms Related to NSAID-Induced Gastropathy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cystitis, Interstitial; Cytochrome P-450 CYP2C9; | 2015 |
Mechanism of action of celecoxib on normal and acid-challenged gastric mucosa.
Topics: Animals; Catalase; Celecoxib; Cyclooxygenase 2 Inhibitors; Gastric Mucosa; Gastritis; Glutathione; G | 2009 |
Celecoxib inhibits CD133-positive cell migration via reduction of CCR2 in Helicobacter pylori-infected Mongolian gerbils.
Topics: AC133 Antigen; Adenocarcinoma; Animals; Antigens, CD; Blotting, Western; Celecoxib; Cell Count; Cell | 2010 |
Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Comorbidity; Cyc | 2012 |
Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice.
Topics: Adenoma; Angiogenesis Inhibitors; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; | 2003 |
Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Celecoxib; Cyclooxygenase 2; Cyclo | 2004 |
Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Ca | 2005 |
[Safety of specific cyclo-oxygenase 2 inhibitors].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cost-Benefit Analysis; Cyclooxygenase I | 2001 |